Kasner SE, Siegler JE, Zamzam A, Kleindorfer D, On behalf of the VISTA-Acute Collaborators. Expanding eligibility in stroke prevention trials to patients with early disability. Journal of Stroke and Cerebrovascular Diseases. 2019 (In Press)
READ DETAILSAbdul-Rahim AH, Dickie DA, Selvarajah JR, Lees KR, Quinn TJ ,On behalf of VISTA Collaborators. “Stroke aetiological classification reliability and effect on trial sample size: systematic review, meta-analysis and statistical modelling,” Trials (2019) 20:107
READ DETAILSChou C-Y, Development of A Computerized Adaptive Testing System for Comprehensive Assessments of Functions in Patients with Stroke.
READ DETAILSPhan TG, Beare R, Bath PM, Ievliva S, Ho S, Ly J, Thrift AG, Srikanth VK, Ma H, for the VISTA Collaborators, Effect of alteplase, benzodiazepines and beta-blocker on post-stroke pneumonia: Exploration of VISTA-Acute, PLoS One, 2023 May 1;18(5):e0281617,doi: 1371/journal.pone.0281617. eCollection 2023.
READ DETAILSRustam Al-Shahi Salman et al, on behalf of the VISTA-ICH and the ICH Growth Individual Patient Data Meta-analysis Collaborators. “Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.” The Lancet Neurology; DOI:https://doi.org/10.1016/S1474-4422(18)30253-9
READ DETAILS